Fw: Ref.: (LML) Histopathological Diagnosis of Leprosy

 

 

 
Leprosy Mailing List – September 22,  2021

 

Ref.:  (LML) Histopathological Diagnosis of Leprosy

 

From:  Ben Naafs, Munnekeburen, the Netherlands

 

Dear Pieter,

 

It was a real pleasure to read the book: Histopathological Diagnosis of Leprosy, written by Cleverson Teixeira Soares (LML, September 4, 2021). It is a timely follow-up of the leprosy histopathological textbooks of other leading pathologists such as Dennis Ridley, Charles K. Job and David Scollard.

There have been excellent chapters in books and guides on pathology and leprosy. However, books that focus only on leprosy histopathology are scarce. The author worked for a long time with the late Raoul Fleury, one of the best leprosy pathologists, often with strong opinions. He extended this experience with new techniques and interpreted the findings against commonly accepted schools of thought.

The book is not only suitable for the pathologist but also for the clinician. It is clearly written and the clinical and histopathological photographs fit well with the text, a text based on observations and interpretation of these observation. Each chapter can be read separately because the introduction of each chapter contains the basics and then the topic of the chapter and differential diagnoses are discussed. The histopathological images have been carefully chosen to clarify the interpretation and are of high quality. The clinical pictures provided by Casio Ghidella, once a student of Diltor Opromolla and now like his teacher an excellent clinician visualizing the clinical picture for the pathologist.

This book is more than just an enchiridion, it teaches and clarifies and helps the studying reader to understand. It is worth having and digesting.

 

 

Ben Naafs

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/4822e65d-5605-495a-b6e1-8ac045b61899n%40googlegroups.com.

Fw: Ref.: (LML) Leprosy Review - Sept 2021

 

Leprosy Mailing List – September 21, 2021

 

Ref.:  (LML) Leprosy Review - Sept 2021

From:  Paul Saunderson, Ålesund, Norway

 

 

Dear Pieter,

I'm happy to forward to you the Contents of the September issue of Leprosy Review.

All papers are freely available online at https://leprosyreview.org/articles

With kind regards,

Paul

 

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/5c8460c6-7e85-483b-9e4b-b9e815453237n%40googlegroups.com.

Fw: Ref.: (LML) Leprosy Reactions New Knowledge on Pathophysiology, Diagnosis, Treatment and Prevention - Frontiers Research Topic

 

Leprosy Mailing List – September 21, 2021,  2021

 

Ref.:  (LML) Leprosy Reactions New Knowledge on Pathophysiology, Diagnosis, Treatment and Prevention - Frontiers Research Topic

From:  Patricia Rosa and Cleverson Soares, Bauru, Brazil

 

 

Dear Pieter, 

 

Frontiers in Medicine has launched a new special topic in leprosy. 

The topic is related to "Leprosy reactions: new knowledge on pathophysiology, diagnosis, treatment, and prevention".

We would like to invite the experts of this group to contribute with publications on this topic.   

All information can be found on the link:

https://www.frontiersin.org/research-topics/25630/leprosy-reactions-new-knowledge-on-pathophysiology-diagnosis-treatment-and-prevention

Best Regards, 

 

 

Patricia Rosa and Cleverson Soares

Lauro de Souza Lima Institute

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/066d921c-b34d-4751-bc77-1ea8eecd48b5n%40googlegroups.com.

Ref.: (LML) Infolep monthly overview of new publications on leprosy - Sep '21

Note editor:  maybe some of you did receive this message already, but because of the problems we had not everyone on our LML list.

Leprosy Mailing List – September 7,  2021

 

Ref.:  (LML) Infolep monthly overview of new publications on leprosy - Sep '21 

 

From:  Anniek Akerboom, Amsterdam, the Netherlands

 

 

Dear colleagues, 

From now on Boolean operators can be used when searching the Infolep database! You can use operators, such as AND, OR, NOT, including truncation, wildcards and proximity, to make your search more specific. The "old" way of searching, by entering key words and using the filter boxes on the left, will still work as well. If you have any questions, feedback or need any help using this new functionality, please let us know.

A new Rehabilitation Resource Repository has been launched by the Learning, Acting and Building for Rehabilitation in Health Systems (ReLAB-HS) consortium. The repository provides an online portal that catalogues evidence-based rehabilitation resources, such as manuals, toolkits, policies, protocols, and guides that inform and support service development and delivery.

PerMaTa South Sulawesi launched their own website. PerMaTa is a non-profit organization by and for people affected by leprosy in Indonesia. The website provides information about their activities to support and inform people affected by leprosy and their communities (in English and in Bahasa Indonesia). Take a look!

Below you will find the list with new publications on leprosy and interesting events. Feel free to contact me to receive full-text versions if these cannot be found through the Infolep portal. Also, I would be happy to assist you with literature searches on Infolep.

Warm regards,

Anniek Akerboom

Infolep Coordinator
www.leprosy-information.org
a.ake...@infolep.org
 

 

 

Highlighted

 

Safety in administering medicines for neglected tropical diseases
World Health Organization. 2021.
 

Ending the neglect to attain the sustainable development goals. A Global Strategy on Water, Sanitation and Hygiene to Combat Neglected Tropical Diseases 2021–2030
World Health Organization. 2021.
 

Ending the neglect to attain the sustainable development goals: a framework for monitoring and evaluating progress of the road map for neglected tropical diseases 2021−2030
World Health Organization. 2021.
 

 

 

Leprosy & COVID-19

 

The influence of leprosy-related clinical and epidemiological variables in the occurrence and severity of COVID-19: A prospective real-world cohort study.
Cerqueira S, Deps P, Cunha D, et al. PLoS neglected tropical diseases. 2021; 15 (7) : e0009635.
 

An assessment of the reported impact of 
Impact of the coronavirus disease 2019 on the diagnoses of Hansen's disease in Brazil.
Marques N, Marques N, Cardozo I, et al. Revista da Sociedade Brasileira de Medicina Tropical. 2021.
 

 

 

New publications

 

Detection of anti-M. leprae antibodies in children in leprosy-endemic areas: A systematic review.
Pierneef L, van Hooij A, Taal A, et al. PLoS neglected tropical diseases. 2021; 15 (8) : e0009667.
 

Clinico-Epidemiological Spectrum of Childhood Leprosy in Post-Elimination Era: A Multi-Centre, Cross-Sectional Study from West Bengal
Pradhan S, Podder I, Chowdhury SN, et al. Indian Journal of Leprosy. 2021.
 

Individual and community factors determining delayed leprosy case detection: A systematic review.
Dharmawan Y, Fuady A, Korfage I, et al. PLoS neglected tropical diseases. 2021; 15 (8) : e0009651.
 

Situation of the foot at risk due to leprosy in the municipality of Rio de Janeiro
Abreu C, Vilhena M, de Miranda ST, et al. Leprosy Review. Lepra. 2021; 92 (2) : 124-133.
 

Bridging the Divide Between Health, Social Development and Environmental Interventions: An Example From The Leprosy Mission
Pender JS. Christian Journal for Global Health. Christian Journal for Global Health. 2021; 8 (1) : 34-41.
 

Disabilities in leprosy: construction and validation of instrument on knowledge and attitude of professionals.
de Santana E, de Brito K, Andrade S, et al. Revista brasileira de enfermagem. 2021; 74 (5) : e20200862.
 

Potential Role of CXCL10 in Monitoring Response to Treatment in Leprosy Patients.
Ferreira H, Mendes M, Barbosa M, et al. Frontiers in immunology. 2021.
 

Clinical prediction rules for the diagnosis of neuritis in leprosy.
Giesel L, Hökerberg Y, Pitta I, et al. BMC infectious diseases. 2021; 21 (1) : 858. 
 

Cyclosporin A as an Alternative Neuroimmune Strategy to Control Neurites and Recover Neuronal Tissues in Leprosy.
de Jesus J, de Sena C, Macchi B, et al. Neuroimmunomodulation. 2021.
 

Leprous Neuropathy: Observational Study Highlighting the Role of Electrophysiology in Early Diagnosis.
Vijayan B, Dominic M, Nair V. Journal of neurosciences in rural practice. 2021; 12 (3) : 530-534. 
 

Epitope mapping from Mycobacterium leprae proteins: Convergent data from in silico and in vitro approaches for serodiagnosis of leprosy.
Soares B, Teixeira K, de Santana J, et al. Molecular immunology. 2021.
 

Neutrophil NETworking in ENL: Potential as a Putative Biomarker: Future Insights.
Sahu S, Sharma K, Sharma M, et al. Frontiers in medicine. 2021.
 

Consensus in Brazil on the renaming of leprosy to Hansen's disease.
Delboni L, Deps P. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2021.

 

PEP4LEP study protocol: integrated skin screening and SDR-PEP administration for leprosy prevention: comparing the effectiveness and feasibility of a community-based intervention to a health centre-based intervention in Ethiopia, Mozambique and Tanzania.
Schoenmakers A, Hambridge T, van Wijk R, et al. BMJ open. 2021; 11 (8) : e046125. 
 

Changing perception and improving knowledge of leprosy: An intervention study in Uttar Pradesh, India.
van 't Noordende A, Lisam S, Singh V, et al. PLoS neglected tropical diseases. 2021; 15 (8) : e0009654.
 

Disability-related stigma and discrimination in sub-Saharan Africa and South Asia: a systematic literature review.
Sightsavers. 2021.
 

Estimating underreporting of leprosy in Brazil using a Bayesian approach.
de Oliveira G, Oliveira J, Pescarini J, et al. PLoS neglected tropical diseases. 2021; 15 (8) : e0009700. 
 

The development of a Portuguese mobile application for clinical support in detecting leprosy suspects
Canci B, Pereira EG, Sakata-So K, et al. Leprosy Review. Lepra. 2021; 92 (2) : 141-151.
 

Application of digital technologies to leprosy programmes
Warne G, Mukhier M. Leprosy Review. Lepra. 2021; 92 (2) : 182-185. 
 

Towards zero leprosy: Dream or vision?
Richardus J. The Indian journal of medical research. 2021; 153 (4) : 401-403.
 

Putative pathogen-selected polymorphisms in the PKLR gene are associated with mycobacterial susceptibility in Brazilian and African populations.
Bezerra O, Alvarado-Arnez L, Mabunda N, et al. PLoS neglected tropical diseases. 2021; 15 (8) : e0009434.
 

Unusual presentations of a severe type 2 leprosy reaction mimicking sepsis induced by helminth infection.
Menaldi S, Dinakrisma A, Thio H, et al. PLoS neglected tropical diseases. 2021; 15 (7) : e0009453.
 

Serum IgA Antibodies Specific to Antigens as Biomarkers for Leprosy Detection and Household Contact Tracking.
Silva K, de Oliveira E, Elias C, et al. Frontiers in medicine. 2021.
 

Epidemiological characteristics and temporal trends of new leprosy cases in Brazil: 2006 to 2017.
Pescarini J, Teixeira C, da Silva N, et al. Cadernos de saude publica. 2021; 37 (7) : e00130020.
 

Equal rates of drug resistance in leprosy cases with relapse and recurrent /chronic type 2 reaction; Time to revise the guidelines for drug resistance testing in leprosy.
Narang T, Kamat D, Thakur V, et al. Clinical and experimental dermatology. 2021.

 

 

 

Events

 

NNN Conference 2021
7-9 Sep 2021 | Virtual
 

COR-NTD webinars (Virtual):

Leveraging New Technology and Methods to Diagnose NTDs
Day 1: 23 Sep 2021 - Register link
Day 2: 24 Sep 2021 - Register link

Improving the Patient's Journey: The Impact and Efficacy of Training Tools for NTDs
27 Sep 2021

Monitoring Transmission of NTDs
30 Sep 2021
 

12th European Congress on Tropical Medicine and International Health
28 Sep - 1 Oct 2021 | Virtual
 

 

Call for Entries: Virtual Innovation Lab at COR-NTD
Deadline to apply: 15 Sep 2021
If you have been involved with the development of a technology or advancement with the potential to help NTD programs, we invite you to apply to showcase your innovation for the hundreds of researchers, donors and program implementers who will attend the COR-NTD virtual meeting. The Innovation Lab will be held on November 8.
 

RSTMH 2021 meeting: Drug resistant infections – causes, consequences and considerations
11-12 Oct 2021 | Virtual
 

The tenth EDCTP Forum
17-21 Oct 2021 | Virtual

 

 

Links

 

Info Hansen - A innovative hub for knowledge sharing about Hansen's Disease
 

ALLF - Official website of the Association des Léprologues de Langue Française
 

LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in leprosy to share ideas, information, experiences and questions
 

InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs)

 

ILEP newsletter archive

GPZL newsletter archive

WHO Goodwill Ambassador's Leprosy Bulletin

Leprosy Review

Leprosy Review Repository (1928-2001)

Fontilles Revista de Leprología

Indian Journal of Leprosy

Hansenologia Internationalis

 

GDPR & the Infolep newsletter

 
New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regards to the GDPR, including our privacy statement and mailing list.

Infolep sends out monthly e-mails with an overview of recent publications on leprosy and related issues. The purpose of this activity is to keep subscribers up to date.

Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else.

You can update your preferences or unsubscribe from this list at any time.

 

 

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << edit...@gmail.com

Fw: Ref.: (LML) Ending the neglect

 

Note editor: May be some of you did receive this message already, but not all on the LML list.

Leprosy Mailing List – September 9,  2021 

 

Ref.:  (LML) Ending the neglect 

 

 

From:  Joel Almeida, London and Mumbai 

  

 

Dear Pieter and colleagues, 

 

What is life like for persons who have experienced HD (leprosy)? They speak:

https://youtu.be/3eeOCdxlVJk 

 

Human rights lawyers have approached a High Court with a Public Interest Litigation in an attempt to end the neglect and exclusion. That is great work. 

 

Even non-lawyers can make an important contribution to respecting human dignity, as enshrined in the Universal Declaration of Human Rights. We can do this by replacing public misinformation with reliable and scientifically accurate public information. For example, persons with PB (paucibacillary) HD are nearly all non-infectious even before treatment. Giving them anti-microbials makes no difference to the risk of new HD cases among their household contacts. Nobody need fear these individuals. They merely happened to be exposed to concentrated viable bacilli shed by unprotected but anergic patients. 

 

We could ensure that no anergic patient in an endemic area remains unprotected against reinfection by HD bacilli after 12 months of MDT. Not only would that show respect for these patients, but also it would allow us to end reinfection and so end transmission reasonably rapidly. It would also spare them a 600% increase in the risk of the painful, swollen nerves of ENL neuritis. We can do this. 

 

Joel Almeida

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << edit...@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/033f974f-0e54-4b57-9803-2b775f4534b1n%40googlegroups.com.

Ref.: (LML) Google Group Leprosy Mailing List

 
Leprosy Mailing List – September 20,  2021 

 

Ref.:  (LML) Google Group Leprosy Mailing List 

 

From:  Pieter Schreuder, Maastricht, the Netherlands 

---

  

Dear colleagues, 

 

 

The past two weeks we had a serious problem with our Google Group: we could not send out messages; messages were deleted as soon as we pushed the send key. The cause could not be found; we had to reconstitute Google Group LML. Hopefully, the problem has been solved.  

 

The only advice I can give that is that if we have a similar problem in the future, and you do not receive any messages from us, please check our blog:  

 

LML blog link: http://leprosymailinglist.blogspot.it/ 

 

 

Best regards, 

 

 

Pieter AM Schreuder 

 

---

LML - S Deepak, B Naafs, S Noto and P Schreuder 

LML blog link: http://leprosymailinglist.blogspot.it/ 

Contact: Dr Pieter Schreuder << editorlml@gmail.com  

New LML Google Group

All the Leprosy Mailing List (LML) messages are sent through emails by using the Google Groups. For the last few days, the Google Group for LML was facing some problems. In spite of different attempts, it was not possible to overcome those problems.

Finally, it has been decided to create a new Google Group for LML. Therefore, all the existing LML members will receive an invitation to join the LML google group. If you wish to continue receiving the LML emails, please accept that invitation and join the group.

Any inconvenience to the LML members is regretted. 

Fw: Ref.: (LML) Histopathological Diagnosis of Leprosy

 

 
Leprosy Mailing List – September 4,  2021

 

Ref.:  (LML) Histopathological Diagnosis of Leprosy

From:  Cleverson Teixeira Soares, Bauru, Brazil

 

 

Dear Dr Pieter Schreuder,

I would like to feature my recently published book "Histopathological Diagnosis of Leprosy" on the "Leprosy Mailing List Blog". It is a book that describes the histopathological patterns of common and special forms of leprosy, as well as the reactional phenomena (T1R and T2R) and the regression of leprosy lesions.

 

It is a useful book for understanding the pathophysiology of leprosy and helping clinicians, scientists, medical students, and other professionals who deal with leprosy daily.

 

I hope you can share it on the blog. Attached are photos of book and flyer

Yours sincerely,

Cleverson.

Pathologist
Lauro de Souza Lima Institute

Bauru - São Paulo - Brazil

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/aab57435-b7ba-4f2b-ac96-3f7f46718ebbn%40googlegroups.com.